ESR1 and breast cancer: Chromatin immunoprecipitation (ChIP) assays showed that UCHL1 knockdown enhanced recruitment of ER to promoter regions of Nuclear Receptor Interacting Protein (NRIP1) and CCND1 genes in ER− breast cancer cells treated with estrogen.